Global Acne Vulgaris Treatment Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Acne Vulgaris Treatment market report explains the definition, types, applications, major countries, and major players of the Acne Vulgaris Treatment market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Paratek Pharmaceuticals Inc

    • Cutanea Life Sciences Inc

    • Novan Inc

    • Lee's Pharmaceutical Holdings Ltd

    • Hovione FarmaCiencia SA

    • Novabiotics Ltd

    • Dermira Inc

    • Galderma SA

    • LEO Pharma A/S

    • Ensol Biosciences Inc

    • Common Pharma Inc

    • Phosphagenics Ltd

    • Pfizer Inc

    • Foamix Pharmaceuticals Ltd

    • Helix BioMedix Inc

    • Novartis AG

    • GlaxoSmithKline Plc

    • ELORAC Inc

    By Type:

    • CB-0601

    • CJM-112

    • CLS-007

    • Dapsone

    • DFD-10

    • DLX-2323

    • Others

    By End-User:

    • Clinic

    • Hospital

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Acne Vulgaris Treatment Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Acne Vulgaris Treatment Outlook to 2028- Original Forecasts

    • 2.2 Acne Vulgaris Treatment Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Acne Vulgaris Treatment Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Acne Vulgaris Treatment Market- Recent Developments

    • 6.1 Acne Vulgaris Treatment Market News and Developments

    • 6.2 Acne Vulgaris Treatment Market Deals Landscape

    7 Acne Vulgaris Treatment Raw Materials and Cost Structure Analysis

    • 7.1 Acne Vulgaris Treatment Key Raw Materials

    • 7.2 Acne Vulgaris Treatment Price Trend of Key Raw Materials

    • 7.3 Acne Vulgaris Treatment Key Suppliers of Raw Materials

    • 7.4 Acne Vulgaris Treatment Market Concentration Rate of Raw Materials

    • 7.5 Acne Vulgaris Treatment Cost Structure Analysis

      • 7.5.1 Acne Vulgaris Treatment Raw Materials Analysis

      • 7.5.2 Acne Vulgaris Treatment Labor Cost Analysis

      • 7.5.3 Acne Vulgaris Treatment Manufacturing Expenses Analysis

    8 Global Acne Vulgaris Treatment Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Acne Vulgaris Treatment Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Acne Vulgaris Treatment Export by Region (Top 10 Countries) (2017-2028)

    9 Global Acne Vulgaris Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global Acne Vulgaris Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global CB-0601 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global CJM-112 Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global CLS-007 Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Dapsone Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global DFD-10 Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global DLX-2323 Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Acne Vulgaris Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Acne Vulgaris Treatment Market Analysis and Outlook till 2022

    • 10.1 Global Acne Vulgaris Treatment Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Acne Vulgaris Treatment Consumption (2017-2022)

      • 10.2.2 Canada Acne Vulgaris Treatment Consumption (2017-2022)

      • 10.2.3 Mexico Acne Vulgaris Treatment Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Acne Vulgaris Treatment Consumption (2017-2022)

      • 10.3.2 UK Acne Vulgaris Treatment Consumption (2017-2022)

      • 10.3.3 Spain Acne Vulgaris Treatment Consumption (2017-2022)

      • 10.3.4 Belgium Acne Vulgaris Treatment Consumption (2017-2022)

      • 10.3.5 France Acne Vulgaris Treatment Consumption (2017-2022)

      • 10.3.6 Italy Acne Vulgaris Treatment Consumption (2017-2022)

      • 10.3.7 Denmark Acne Vulgaris Treatment Consumption (2017-2022)

      • 10.3.8 Finland Acne Vulgaris Treatment Consumption (2017-2022)

      • 10.3.9 Norway Acne Vulgaris Treatment Consumption (2017-2022)

      • 10.3.10 Sweden Acne Vulgaris Treatment Consumption (2017-2022)

      • 10.3.11 Poland Acne Vulgaris Treatment Consumption (2017-2022)

      • 10.3.12 Russia Acne Vulgaris Treatment Consumption (2017-2022)

      • 10.3.13 Turkey Acne Vulgaris Treatment Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Acne Vulgaris Treatment Consumption (2017-2022)

      • 10.4.2 Japan Acne Vulgaris Treatment Consumption (2017-2022)

      • 10.4.3 India Acne Vulgaris Treatment Consumption (2017-2022)

      • 10.4.4 South Korea Acne Vulgaris Treatment Consumption (2017-2022)

      • 10.4.5 Pakistan Acne Vulgaris Treatment Consumption (2017-2022)

      • 10.4.6 Bangladesh Acne Vulgaris Treatment Consumption (2017-2022)

      • 10.4.7 Indonesia Acne Vulgaris Treatment Consumption (2017-2022)

      • 10.4.8 Thailand Acne Vulgaris Treatment Consumption (2017-2022)

      • 10.4.9 Singapore Acne Vulgaris Treatment Consumption (2017-2022)

      • 10.4.10 Malaysia Acne Vulgaris Treatment Consumption (2017-2022)

      • 10.4.11 Philippines Acne Vulgaris Treatment Consumption (2017-2022)

      • 10.4.12 Vietnam Acne Vulgaris Treatment Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Acne Vulgaris Treatment Consumption (2017-2022)

      • 10.5.2 Colombia Acne Vulgaris Treatment Consumption (2017-2022)

      • 10.5.3 Chile Acne Vulgaris Treatment Consumption (2017-2022)

      • 10.5.4 Argentina Acne Vulgaris Treatment Consumption (2017-2022)

      • 10.5.5 Venezuela Acne Vulgaris Treatment Consumption (2017-2022)

      • 10.5.6 Peru Acne Vulgaris Treatment Consumption (2017-2022)

      • 10.5.7 Puerto Rico Acne Vulgaris Treatment Consumption (2017-2022)

      • 10.5.8 Ecuador Acne Vulgaris Treatment Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Acne Vulgaris Treatment Consumption (2017-2022)

      • 10.6.2 Kuwait Acne Vulgaris Treatment Consumption (2017-2022)

      • 10.6.3 Oman Acne Vulgaris Treatment Consumption (2017-2022)

      • 10.6.4 Qatar Acne Vulgaris Treatment Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Acne Vulgaris Treatment Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Acne Vulgaris Treatment Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Acne Vulgaris Treatment Consumption (2017-2022)

      • 10.7.2 South Africa Acne Vulgaris Treatment Consumption (2017-2022)

      • 10.7.3 Egypt Acne Vulgaris Treatment Consumption (2017-2022)

      • 10.7.4 Algeria Acne Vulgaris Treatment Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Acne Vulgaris Treatment Consumption (2017-2022)

      • 10.8.2 New Zealand Acne Vulgaris Treatment Consumption (2017-2022)

    11 Global Acne Vulgaris Treatment Competitive Analysis

    • 11.1 Paratek Pharmaceuticals Inc

      • 11.1.1 Paratek Pharmaceuticals Inc Company Details

      • 11.1.2 Paratek Pharmaceuticals Inc Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Paratek Pharmaceuticals Inc Acne Vulgaris Treatment Main Business and Markets Served

      • 11.1.4 Paratek Pharmaceuticals Inc Acne Vulgaris Treatment Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Cutanea Life Sciences Inc

      • 11.2.1 Cutanea Life Sciences Inc Company Details

      • 11.2.2 Cutanea Life Sciences Inc Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Cutanea Life Sciences Inc Acne Vulgaris Treatment Main Business and Markets Served

      • 11.2.4 Cutanea Life Sciences Inc Acne Vulgaris Treatment Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Novan Inc

      • 11.3.1 Novan Inc Company Details

      • 11.3.2 Novan Inc Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Novan Inc Acne Vulgaris Treatment Main Business and Markets Served

      • 11.3.4 Novan Inc Acne Vulgaris Treatment Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Lee's Pharmaceutical Holdings Ltd

      • 11.4.1 Lee's Pharmaceutical Holdings Ltd Company Details

      • 11.4.2 Lee's Pharmaceutical Holdings Ltd Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Lee's Pharmaceutical Holdings Ltd Acne Vulgaris Treatment Main Business and Markets Served

      • 11.4.4 Lee's Pharmaceutical Holdings Ltd Acne Vulgaris Treatment Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Hovione FarmaCiencia SA

      • 11.5.1 Hovione FarmaCiencia SA Company Details

      • 11.5.2 Hovione FarmaCiencia SA Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Hovione FarmaCiencia SA Acne Vulgaris Treatment Main Business and Markets Served

      • 11.5.4 Hovione FarmaCiencia SA Acne Vulgaris Treatment Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Novabiotics Ltd

      • 11.6.1 Novabiotics Ltd Company Details

      • 11.6.2 Novabiotics Ltd Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Novabiotics Ltd Acne Vulgaris Treatment Main Business and Markets Served

      • 11.6.4 Novabiotics Ltd Acne Vulgaris Treatment Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Dermira Inc

      • 11.7.1 Dermira Inc Company Details

      • 11.7.2 Dermira Inc Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Dermira Inc Acne Vulgaris Treatment Main Business and Markets Served

      • 11.7.4 Dermira Inc Acne Vulgaris Treatment Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Galderma SA

      • 11.8.1 Galderma SA Company Details

      • 11.8.2 Galderma SA Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Galderma SA Acne Vulgaris Treatment Main Business and Markets Served

      • 11.8.4 Galderma SA Acne Vulgaris Treatment Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 LEO Pharma A/S

      • 11.9.1 LEO Pharma A/S Company Details

      • 11.9.2 LEO Pharma A/S Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 LEO Pharma A/S Acne Vulgaris Treatment Main Business and Markets Served

      • 11.9.4 LEO Pharma A/S Acne Vulgaris Treatment Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Ensol Biosciences Inc

      • 11.10.1 Ensol Biosciences Inc Company Details

      • 11.10.2 Ensol Biosciences Inc Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Ensol Biosciences Inc Acne Vulgaris Treatment Main Business and Markets Served

      • 11.10.4 Ensol Biosciences Inc Acne Vulgaris Treatment Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Common Pharma Inc

      • 11.11.1 Common Pharma Inc Company Details

      • 11.11.2 Common Pharma Inc Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Common Pharma Inc Acne Vulgaris Treatment Main Business and Markets Served

      • 11.11.4 Common Pharma Inc Acne Vulgaris Treatment Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Phosphagenics Ltd

      • 11.12.1 Phosphagenics Ltd Company Details

      • 11.12.2 Phosphagenics Ltd Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Phosphagenics Ltd Acne Vulgaris Treatment Main Business and Markets Served

      • 11.12.4 Phosphagenics Ltd Acne Vulgaris Treatment Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 Pfizer Inc

      • 11.13.1 Pfizer Inc Company Details

      • 11.13.2 Pfizer Inc Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 Pfizer Inc Acne Vulgaris Treatment Main Business and Markets Served

      • 11.13.4 Pfizer Inc Acne Vulgaris Treatment Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    • 11.14 Foamix Pharmaceuticals Ltd

      • 11.14.1 Foamix Pharmaceuticals Ltd Company Details

      • 11.14.2 Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.14.3 Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Main Business and Markets Served

      • 11.14.4 Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Product Portfolio

      • 11.14.5 Recent Research and Development Strategies

    • 11.15 Helix BioMedix Inc

      • 11.15.1 Helix BioMedix Inc Company Details

      • 11.15.2 Helix BioMedix Inc Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.15.3 Helix BioMedix Inc Acne Vulgaris Treatment Main Business and Markets Served

      • 11.15.4 Helix BioMedix Inc Acne Vulgaris Treatment Product Portfolio

      • 11.15.5 Recent Research and Development Strategies

    • 11.16 Novartis AG

      • 11.16.1 Novartis AG Company Details

      • 11.16.2 Novartis AG Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.16.3 Novartis AG Acne Vulgaris Treatment Main Business and Markets Served

      • 11.16.4 Novartis AG Acne Vulgaris Treatment Product Portfolio

      • 11.16.5 Recent Research and Development Strategies

    • 11.17 GlaxoSmithKline Plc

      • 11.17.1 GlaxoSmithKline Plc Company Details

      • 11.17.2 GlaxoSmithKline Plc Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.17.3 GlaxoSmithKline Plc Acne Vulgaris Treatment Main Business and Markets Served

      • 11.17.4 GlaxoSmithKline Plc Acne Vulgaris Treatment Product Portfolio

      • 11.17.5 Recent Research and Development Strategies

    • 11.18 ELORAC Inc

      • 11.18.1 ELORAC Inc Company Details

      • 11.18.2 ELORAC Inc Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.18.3 ELORAC Inc Acne Vulgaris Treatment Main Business and Markets Served

      • 11.18.4 ELORAC Inc Acne Vulgaris Treatment Product Portfolio

      • 11.18.5 Recent Research and Development Strategies

    12 Global Acne Vulgaris Treatment Market Outlook by Types and Applications to 2028

    • 12.1 Global Acne Vulgaris Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global CB-0601 Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global CJM-112 Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global CLS-007 Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Dapsone Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global DFD-10 Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.6 Global DLX-2323 Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.7 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Acne Vulgaris Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Acne Vulgaris Treatment Market Analysis and Outlook to 2028

    • 13.1 Global Acne Vulgaris Treatment Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Acne Vulgaris Treatment Consumption Forecast (2022-2028)

      • 13.2.2 Canada Acne Vulgaris Treatment Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Acne Vulgaris Treatment Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Acne Vulgaris Treatment Consumption Forecast (2022-2028)

      • 13.3.2 UK Acne Vulgaris Treatment Consumption Forecast (2022-2028)

      • 13.3.3 Spain Acne Vulgaris Treatment Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Acne Vulgaris Treatment Consumption Forecast (2022-2028)

      • 13.3.5 France Acne Vulgaris Treatment Consumption Forecast (2022-2028)

      • 13.3.6 Italy Acne Vulgaris Treatment Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Acne Vulgaris Treatment Consumption Forecast (2022-2028)

      • 13.3.8 Finland Acne Vulgaris Treatment Consumption Forecast (2022-2028)

      • 13.3.9 Norway Acne Vulgaris Treatment Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Acne Vulgaris Treatment Consumption Forecast (2022-2028)

      • 13.3.11 Poland Acne Vulgaris Treatment Consumption Forecast (2022-2028)

      • 13.3.12 Russia Acne Vulgaris Treatment Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Acne Vulgaris Treatment Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Acne Vulgaris Treatment Consumption Forecast (2022-2028)

      • 13.4.2 Japan Acne Vulgaris Treatment Consumption Forecast (2022-2028)

      • 13.4.3 India Acne Vulgaris Treatment Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Acne Vulgaris Treatment Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Acne Vulgaris Treatment Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Acne Vulgaris Treatment Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Acne Vulgaris Treatment Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Acne Vulgaris Treatment Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Acne Vulgaris Treatment Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Acne Vulgaris Treatment Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Acne Vulgaris Treatment Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Acne Vulgaris Treatment Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Acne Vulgaris Treatment Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Acne Vulgaris Treatment Consumption Forecast (2022-2028)

      • 13.5.3 Chile Acne Vulgaris Treatment Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Acne Vulgaris Treatment Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Acne Vulgaris Treatment Consumption Forecast (2022-2028)

      • 13.5.6 Peru Acne Vulgaris Treatment Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Acne Vulgaris Treatment Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Acne Vulgaris Treatment Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Acne Vulgaris Treatment Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Acne Vulgaris Treatment Consumption Forecast (2022-2028)

      • 13.6.3 Oman Acne Vulgaris Treatment Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Acne Vulgaris Treatment Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Acne Vulgaris Treatment Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Acne Vulgaris Treatment Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Acne Vulgaris Treatment Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Acne Vulgaris Treatment Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Acne Vulgaris Treatment Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Acne Vulgaris Treatment Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Acne Vulgaris Treatment Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Acne Vulgaris Treatment Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Acne Vulgaris Treatment

    • Figure of Acne Vulgaris Treatment Picture

    • Table Global Acne Vulgaris Treatment Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Acne Vulgaris Treatment Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global CB-0601 Consumption and Growth Rate (2017-2022)

    • Figure Global CJM-112 Consumption and Growth Rate (2017-2022)

    • Figure Global CLS-007 Consumption and Growth Rate (2017-2022)

    • Figure Global Dapsone Consumption and Growth Rate (2017-2022)

    • Figure Global DFD-10 Consumption and Growth Rate (2017-2022)

    • Figure Global DLX-2323 Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Acne Vulgaris Treatment Consumption by Country (2017-2022)

    • Table North America Acne Vulgaris Treatment Consumption by Country (2017-2022)

    • Figure United States Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Figure Canada Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Figure Mexico Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe Acne Vulgaris Treatment Consumption by Country (2017-2022)

    • Figure Germany Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Figure UK Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Figure Spain Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Figure Belgium Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Figure France Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Figure Italy Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Figure Denmark Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Figure Finland Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Figure Norway Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Figure Sweden Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Figure Poland Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Figure Russia Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Figure Turkey Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Table APAC Acne Vulgaris Treatment Consumption by Country (2017-2022)

    • Figure China Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Figure India Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Figure Thailand Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Figure Singapore Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Figure Philippines Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Table South America Acne Vulgaris Treatment Consumption by Country (2017-2022)

    • Figure Brazil Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Figure Colombia Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Figure Chile Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Figure Argentina Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Figure Peru Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Table GCC Acne Vulgaris Treatment Consumption by Country (2017-2022)

    • Figure Bahrain Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Figure Oman Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Figure Qatar Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Table Africa Acne Vulgaris Treatment Consumption by Country (2017-2022)

    • Figure Nigeria Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Africa Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Figure Egypt Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Figure Algeria Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Table Oceania Acne Vulgaris Treatment Consumption by Country (2017-2022)

    • Figure Australia Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Table Paratek Pharmaceuticals Inc Company Details

    • Table Paratek Pharmaceuticals Inc Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Paratek Pharmaceuticals Inc Acne Vulgaris Treatment Main Business and Markets Served

    • Table Paratek Pharmaceuticals Inc Acne Vulgaris Treatment Product Portfolio

    • Table Cutanea Life Sciences Inc Company Details

    • Table Cutanea Life Sciences Inc Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cutanea Life Sciences Inc Acne Vulgaris Treatment Main Business and Markets Served

    • Table Cutanea Life Sciences Inc Acne Vulgaris Treatment Product Portfolio

    • Table Novan Inc Company Details

    • Table Novan Inc Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novan Inc Acne Vulgaris Treatment Main Business and Markets Served

    • Table Novan Inc Acne Vulgaris Treatment Product Portfolio

    • Table Lee's Pharmaceutical Holdings Ltd Company Details

    • Table Lee's Pharmaceutical Holdings Ltd Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lee's Pharmaceutical Holdings Ltd Acne Vulgaris Treatment Main Business and Markets Served

    • Table Lee's Pharmaceutical Holdings Ltd Acne Vulgaris Treatment Product Portfolio

    • Table Hovione FarmaCiencia SA Company Details

    • Table Hovione FarmaCiencia SA Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hovione FarmaCiencia SA Acne Vulgaris Treatment Main Business and Markets Served

    • Table Hovione FarmaCiencia SA Acne Vulgaris Treatment Product Portfolio

    • Table Novabiotics Ltd Company Details

    • Table Novabiotics Ltd Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novabiotics Ltd Acne Vulgaris Treatment Main Business and Markets Served

    • Table Novabiotics Ltd Acne Vulgaris Treatment Product Portfolio

    • Table Dermira Inc Company Details

    • Table Dermira Inc Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dermira Inc Acne Vulgaris Treatment Main Business and Markets Served

    • Table Dermira Inc Acne Vulgaris Treatment Product Portfolio

    • Table Galderma SA Company Details

    • Table Galderma SA Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Galderma SA Acne Vulgaris Treatment Main Business and Markets Served

    • Table Galderma SA Acne Vulgaris Treatment Product Portfolio

    • Table LEO Pharma A/S Company Details

    • Table LEO Pharma A/S Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table LEO Pharma A/S Acne Vulgaris Treatment Main Business and Markets Served

    • Table LEO Pharma A/S Acne Vulgaris Treatment Product Portfolio

    • Table Ensol Biosciences Inc Company Details

    • Table Ensol Biosciences Inc Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ensol Biosciences Inc Acne Vulgaris Treatment Main Business and Markets Served

    • Table Ensol Biosciences Inc Acne Vulgaris Treatment Product Portfolio

    • Table Common Pharma Inc Company Details

    • Table Common Pharma Inc Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Common Pharma Inc Acne Vulgaris Treatment Main Business and Markets Served

    • Table Common Pharma Inc Acne Vulgaris Treatment Product Portfolio

    • Table Phosphagenics Ltd Company Details

    • Table Phosphagenics Ltd Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Phosphagenics Ltd Acne Vulgaris Treatment Main Business and Markets Served

    • Table Phosphagenics Ltd Acne Vulgaris Treatment Product Portfolio

    • Table Pfizer Inc Company Details

    • Table Pfizer Inc Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc Acne Vulgaris Treatment Main Business and Markets Served

    • Table Pfizer Inc Acne Vulgaris Treatment Product Portfolio

    • Table Foamix Pharmaceuticals Ltd Company Details

    • Table Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Main Business and Markets Served

    • Table Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Product Portfolio

    • Table Helix BioMedix Inc Company Details

    • Table Helix BioMedix Inc Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Helix BioMedix Inc Acne Vulgaris Treatment Main Business and Markets Served

    • Table Helix BioMedix Inc Acne Vulgaris Treatment Product Portfolio

    • Table Novartis AG Company Details

    • Table Novartis AG Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Acne Vulgaris Treatment Main Business and Markets Served

    • Table Novartis AG Acne Vulgaris Treatment Product Portfolio

    • Table GlaxoSmithKline Plc Company Details

    • Table GlaxoSmithKline Plc Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Plc Acne Vulgaris Treatment Main Business and Markets Served

    • Table GlaxoSmithKline Plc Acne Vulgaris Treatment Product Portfolio

    • Table ELORAC Inc Company Details

    • Table ELORAC Inc Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table ELORAC Inc Acne Vulgaris Treatment Main Business and Markets Served

    • Table ELORAC Inc Acne Vulgaris Treatment Product Portfolio

    • Figure Global CB-0601 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CJM-112 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CLS-007 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Dapsone Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global DFD-10 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global DLX-2323 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Acne Vulgaris Treatment Consumption Forecast by Country (2022-2028)

    • Table North America Acne Vulgaris Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Acne Vulgaris Treatment Consumption Forecast by Country (2022-2028)

    • Figure Germany Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Acne Vulgaris Treatment Consumption Forecast by Country (2022-2028)

    • Figure China Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Acne Vulgaris Treatment Consumption Forecast by Country (2022-2028)

    • Figure Brazil Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Acne Vulgaris Treatment Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Acne Vulgaris Treatment Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Acne Vulgaris Treatment Consumption Forecast by Country (2022-2028)

    • Figure Australia Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.